AMEUF (Anteris Technologies) YoY EBITDA Growth : -26.18% (As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Anteris Technologies YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Anteris Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -26.18%.

Anteris Technologies's EBITDA per Share for the six months ended in Dec. 2024 was $-2.09.

Anteris Technologies YoY EBITDA Growth Historical Data

The historical data trend for Anteris Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies YoY EBITDA Growth Chart

Anteris Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-251.08

-11.01

-7.39

-36.05

-45.03

Anteris Technologies Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															-10.82	-23.93	-51.28	-46.15	-26.18

Anteris Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Anteris Technologies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-4.187	-	-2.887)	/	\| -2.887 \|
=	-45.03 %

Anteris Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-2.092	-	-1.658)	/	\| -1.658 \|
=	-26.18 %

Anteris Technologies YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Anteris Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (OTCPK:AMEUF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

AVR:Australia

Address

9 Sherwood Road, Level 3, Suite 302, Toowong, QLD, AUS, 4066

Website

https://www.anteristech.com

Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.